Zenos Biomed Private Limited
Founded in 2022 and headquartered in Maharashtra, India.
2022 | Pune, Maharashtra (India) | Active
Zenos Biomed Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
About Zenos Biomed
Zenos Biomed Private Limited (ZBPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 August 2022 (Two years and six months 25 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Ayesha Qureshi and Shital Sonawane serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304PN2022PTC213702
- Company No.
213702
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Food And Beverages
Textile
Who are the key members and board of directors at Zenos Biomed?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayesha Qureshi  | Director | 04-Aug-2022 | Current |
| Shital Sonawane | Director | 04-Aug-2022 | Current |
Financial Performance of Zenos Biomed.
Enhance accessibility to Zenos Biomed's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zenos Biomed?
Unlock access to Zenos Biomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹0.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2024 | State Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Zenos Biomed?
Zenos Biomed has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenos Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenos Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.